Carlson Resigns From Obagi Medical Products

Obagi Medical Products, Inc. announced today that president and chief executive officer Steven R. Carlson has resigned, effective immediately, from those posts and from the company’s board of directors. Albert F. Hummel, a director who has been with the company since 2005, has been appointed as interim president and chief executive officer.

“The board thanks Steve Carlson for his more than five years of service, during which time the Company completed its successful initial public offering, developed and introduced several new products and saw its annual sales revenues grow from $56 million to $104 million,” said board chairman Albert J. Fitzgibbons.

Calling Hummel a “proven manager and seasoned executive” with experience in pharmaceuticals and dermatology, Fitzgibbons added, “We believe he is a person who will ably guide the company through a period of management transition.”